These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31150695)

  • 1. Regulation of MAP kinase-mediated endothelial dysfunction in hyperglycemia via arginase I and eNOS dysregulation.
    Mazrouei S; Sharifpanah F; Caldwell RW; Franz M; Shatanawi A; Muessig J; Fritzenwanger M; Schulze PC; Jung C
    Biochim Biophys Acta Mol Cell Res; 2019 Sep; 1866(9):1398-1411. PubMed ID: 31150695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p32-Dependent p38 MAPK Activation by Arginase II Downregulation Contributes to Endothelial Nitric Oxide Synthase Activation in HUVECs.
    Koo BH; Won MH; Kim YM; Ryoo S
    Cells; 2020 Feb; 9(2):. PubMed ID: 32046324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperglycemia-impaired aortic vasorelaxation mediated through arginase elevation: Role of stress kinase pathways.
    Chandra S; Fulton DJR; Caldwell RB; Caldwell RW; Toque HA
    Eur J Pharmacol; 2019 Feb; 844():26-37. PubMed ID: 30502342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p38 mitogen-activated protein kinase is involved in arginase-II-mediated eNOS-uncoupling in obesity.
    Yu Y; Rajapakse AG; Montani JP; Yang Z; Ming XF
    Cardiovasc Diabetol; 2014 Jul; 13():113. PubMed ID: 25034973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor-alpha induces insulin resistance in endothelial cells via a p38 mitogen-activated protein kinase-dependent pathway.
    Li G; Barrett EJ; Barrett MO; Cao W; Liu Z
    Endocrinology; 2007 Jul; 148(7):3356-63. PubMed ID: 17446186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue-specific up-regulation of arginase I and II induced by p38 MAPK mediates endothelial dysfunction in type 1 diabetes mellitus.
    Pernow J; Kiss A; Tratsiakovich Y; Climent B
    Br J Pharmacol; 2015 Oct; 172(19):4684-98. PubMed ID: 26140333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p38 Mitogen-activated protein kinase (MAPK) increases arginase activity and contributes to endothelial dysfunction in corpora cavernosa from angiotensin-II-treated mice.
    Toque HA; Romero MJ; Tostes RC; Shatanawi A; Chandra S; Carneiro ZN; Inscho EW; Webb RC; Caldwell RB; Caldwell RW
    J Sex Med; 2010 Dec; 7(12):3857-67. PubMed ID: 20807329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of endothelial nitric-oxide synthase by the p38 MAPK in response to black tea polyphenols.
    Anter E; Thomas SR; Schulz E; Shapira OM; Vita JA; Keaney JF
    J Biol Chem; 2004 Nov; 279(45):46637-43. PubMed ID: 15333638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling by eNOS through a superoxide-dependent p42/44 mitogen-activated protein kinase pathway.
    Wang W; Wang S; Nishanian EV; Del Pilar Cintron A; Wesley RA; Danner RL
    Am J Physiol Cell Physiol; 2001 Aug; 281(2):C544-54. PubMed ID: 11443053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pulsatile shear stress on signaling mechanisms controlling nitric oxide production, endothelial nitric oxide synthase phosphorylation, and expression in ovine fetoplacental artery endothelial cells.
    Li Y; Zheng J; Bird IM; Magness RR
    Endothelium; 2005; 12(1-2):21-39. PubMed ID: 16036314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II limits NO production by upregulating arginase through a p38 MAPK-ATF-2 pathway.
    Shatanawi A; Lemtalsi T; Yao L; Patel C; Caldwell RB; Caldwell RW
    Eur J Pharmacol; 2015 Jan; 746():106-14. PubMed ID: 25446432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of p38 mitogen-activated protein kinase in vascular endothelial aging: interaction with Arginase-II and S6K1 signaling pathway.
    Wu Z; Yu Y; Liu C; Xiong Y; Montani JP; Yang Z; Ming XF
    Aging (Albany NY); 2015 Jan; 7(1):70-81. PubMed ID: 25635535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of human endothelial nitric oxide synthase promoter activity by p38 mitogen-activated protein kinase activation.
    Xing F; Jiang Y; Liu J; Zhao K; Mo Y; Liu Z; Zeng Y
    Biochem Cell Biol; 2006 Oct; 84(5):780-8. PubMed ID: 17167542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells.
    Chen C; Jiang J; Lü JM; Chai H; Wang X; Lin PH; Yao Q
    Am J Physiol Heart Circ Physiol; 2010 Jul; 299(1):H193-201. PubMed ID: 20435848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated Rho kinase mediates diabetes-induced elevation of vascular arginase activation and contributes to impaired corpora cavernosa relaxation: possible involvement of p38 MAPK activation.
    Toque HA; Nunes KP; Yao L; Liao JK; Webb RC; Caldwell RB; Caldwell RW
    J Sex Med; 2013 Jun; 10(6):1502-15. PubMed ID: 23566117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginase Inhibition Restores Peroxynitrite-Induced Endothelial Dysfunction via L-Arginine-Dependent Endothelial Nitric Oxide Synthase Phosphorylation.
    Nguyen MC; Park JT; Jeon YG; Jeon BH; Hoe KL; Kim YM; Lim HK; Ryoo S
    Yonsei Med J; 2016 Nov; 57(6):1329-38. PubMed ID: 27593859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of shear stress-induced endothelial nitric-oxide synthase phosphorylation and expression in ovine fetoplacental artery endothelial cells.
    Li Y; Zheng J; Bird IM; Magness RR
    Biol Reprod; 2004 Mar; 70(3):785-96. PubMed ID: 14627548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginase II protein regulates Parkin-dependent p32 degradation that contributes to Ca2+-dependent eNOS activation in endothelial cells.
    Koo BH; Won MH; Kim YM; Ryoo S
    Cardiovasc Res; 2022 Mar; 118(5):1344-1358. PubMed ID: 33964139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperhomocysteinemia and hyperglycemia induce and potentiate endothelial dysfunction via μ-calpain activation.
    Cheng Z; Jiang X; Pansuria M; Fang P; Mai J; Mallilankaraman K; Gandhirajan RK; Eguchi S; Scalia R; Madesh M; Yang X; Wang H
    Diabetes; 2015 Mar; 64(3):947-59. PubMed ID: 25352635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Src kinase mediates angiotensin II-dependent increase in pulmonary endothelial nitric oxide synthase.
    Li X; Lerea KM; Li J; Olson SC
    Am J Respir Cell Mol Biol; 2004 Sep; 31(3):365-72. PubMed ID: 15191917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.